InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Bhaskar Anand, SVP, Chief Accounting Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $554K, reported from Mar 3, 23 to Sep 5, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 5, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 406 | $169.20 | $69K |
| Aug 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 210 | $168.42 | $35K |
| Aug 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 193 | $169.06 | $33K |
| Jun 14, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 2.3K | $102.11 | $239K |
| May 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 136 | $81.10 | $11K |
| May 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 950 | $85.98 | $82K |
| Mar 7, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 165 | $84.58 | $14K |
| Mar 3, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 820 | $87.47 | $72K |